Mefloquine-induced pneumonitis.
Identifieur interne : 000681 ( PubMed/Checkpoint ); précédent : 000680; suivant : 000682Mefloquine-induced pneumonitis.
Auteurs : Patrick Soentjens [Belgique] ; Marc Delanote ; Alfons Van GompelSource :
- Journal of travel medicine [ 1195-1982 ]
Descripteurs français
- KwdFr :
- MESH :
- administration et posologie : Antipaludiques, Méfloquine.
- diagnostic : Pneumopathie infectieuse.
- effets indésirables : Antipaludiques, Méfloquine.
- Adulte d'âge moyen, Femelle, Humains, Paludisme, Pneumopathie infectieuse.
English descriptors
- KwdEn :
- MESH :
- chemical , administration & dosage : Antimalarials, Mefloquine.
- chemical , adverse effects : Antimalarials, Mefloquine.
- chemically induced : Pneumonia.
- diagnosis : Pneumonia.
- prevention & control : Malaria.
- Female, Humans, Middle Aged.
Abstract
Mefloquine is indicated as oral treatment and as prophylaxis for malaria in areas where chloroquine-resistant malaria is present. Gastrointestinal and neuropsychiatric side effects of mefloquine are well known. More severe neuropsychiatric disorders such as psychosis, depression, hallucinations, and seizures are also reported in the literature. We are reporting a case of drug-induced pneumonia due to mefloquine. This diagnosis was confirmed 4 months after the adverse event, after restarting the same malaria prophylaxis, which could be considered as an unintentional provocation test. This is the third case report in the literature of acute lung injury caused by mefloquine.
DOI: 10.1111/j.1708-8305.2006.00037.x
PubMed: 16706949
Affiliations:
Links toward previous steps (curation, corpus...)
Links to Exploration step
pubmed:16706949Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Mefloquine-induced pneumonitis.</title><author><name sortKey="Soentjens, Patrick" sort="Soentjens, Patrick" uniqKey="Soentjens P" first="Patrick" last="Soentjens">Patrick Soentjens</name><affiliation wicri:level="1"><nlm:affiliation>Department of Internal Medicine, University Hospital Gasthuisberg, Leuven, Belgium.</nlm:affiliation><country xml:lang="fr">Belgique</country><wicri:regionArea>Department of Internal Medicine, University Hospital Gasthuisberg, Leuven</wicri:regionArea><wicri:noRegion>Leuven</wicri:noRegion></affiliation></author><author><name sortKey="Delanote, Marc" sort="Delanote, Marc" uniqKey="Delanote M" first="Marc" last="Delanote">Marc Delanote</name></author><author><name sortKey="Van Gompel, Alfons" sort="Van Gompel, Alfons" uniqKey="Van Gompel A" first="Alfons" last="Van Gompel">Alfons Van Gompel</name></author></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="????"><PubDate><MedlineDate>2006 May-Jun</MedlineDate></PubDate></date><idno type="RBID">pubmed:16706949</idno><idno type="pmid">16706949</idno><idno type="doi">10.1111/j.1708-8305.2006.00037.x</idno><idno type="wicri:Area/PubMed/Corpus">000435</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">000435</idno><idno type="wicri:Area/PubMed/Curation">000435</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">000435</idno><idno type="wicri:Area/PubMed/Checkpoint">000681</idno><idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">000681</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">Mefloquine-induced pneumonitis.</title><author><name sortKey="Soentjens, Patrick" sort="Soentjens, Patrick" uniqKey="Soentjens P" first="Patrick" last="Soentjens">Patrick Soentjens</name><affiliation wicri:level="1"><nlm:affiliation>Department of Internal Medicine, University Hospital Gasthuisberg, Leuven, Belgium.</nlm:affiliation><country xml:lang="fr">Belgique</country><wicri:regionArea>Department of Internal Medicine, University Hospital Gasthuisberg, Leuven</wicri:regionArea><wicri:noRegion>Leuven</wicri:noRegion></affiliation></author><author><name sortKey="Delanote, Marc" sort="Delanote, Marc" uniqKey="Delanote M" first="Marc" last="Delanote">Marc Delanote</name></author><author><name sortKey="Van Gompel, Alfons" sort="Van Gompel, Alfons" uniqKey="Van Gompel A" first="Alfons" last="Van Gompel">Alfons Van Gompel</name></author></analytic><series><title level="j">Journal of travel medicine</title><idno type="ISSN">1195-1982</idno></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Antimalarials (administration & dosage)</term><term>Antimalarials (adverse effects)</term><term>Female</term><term>Humans</term><term>Malaria (prevention & control)</term><term>Mefloquine (administration & dosage)</term><term>Mefloquine (adverse effects)</term><term>Middle Aged</term><term>Pneumonia (chemically induced)</term><term>Pneumonia (diagnosis)</term></keywords><keywords scheme="KwdFr" xml:lang="fr"><term>Adulte d'âge moyen</term><term>Antipaludiques (administration et posologie)</term><term>Antipaludiques (effets indésirables)</term><term>Femelle</term><term>Humains</term><term>Méfloquine (administration et posologie)</term><term>Méfloquine (effets indésirables)</term><term>Paludisme ()</term><term>Pneumopathie infectieuse ()</term><term>Pneumopathie infectieuse (diagnostic)</term></keywords><keywords scheme="MESH" type="chemical" qualifier="administration & dosage" xml:lang="en"><term>Antimalarials</term><term>Mefloquine</term></keywords><keywords scheme="MESH" type="chemical" qualifier="adverse effects" xml:lang="en"><term>Antimalarials</term><term>Mefloquine</term></keywords><keywords scheme="MESH" qualifier="administration et posologie" xml:lang="fr"><term>Antipaludiques</term><term>Méfloquine</term></keywords><keywords scheme="MESH" qualifier="chemically induced" xml:lang="en"><term>Pneumonia</term></keywords><keywords scheme="MESH" qualifier="diagnosis" xml:lang="en"><term>Pneumonia</term></keywords><keywords scheme="MESH" qualifier="diagnostic" xml:lang="fr"><term>Pneumopathie infectieuse</term></keywords><keywords scheme="MESH" qualifier="effets indésirables" xml:lang="fr"><term>Antipaludiques</term><term>Méfloquine</term></keywords><keywords scheme="MESH" qualifier="prevention & control" xml:lang="en"><term>Malaria</term></keywords><keywords scheme="MESH" xml:lang="en"><term>Female</term><term>Humans</term><term>Middle Aged</term></keywords><keywords scheme="MESH" xml:lang="fr"><term>Adulte d'âge moyen</term><term>Femelle</term><term>Humains</term><term>Paludisme</term><term>Pneumopathie infectieuse</term></keywords></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">Mefloquine is indicated as oral treatment and as prophylaxis for malaria in areas where chloroquine-resistant malaria is present. Gastrointestinal and neuropsychiatric side effects of mefloquine are well known. More severe neuropsychiatric disorders such as psychosis, depression, hallucinations, and seizures are also reported in the literature. We are reporting a case of drug-induced pneumonia due to mefloquine. This diagnosis was confirmed 4 months after the adverse event, after restarting the same malaria prophylaxis, which could be considered as an unintentional provocation test. This is the third case report in the literature of acute lung injury caused by mefloquine.</div></front></TEI><pubmed><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">16706949</PMID><DateCompleted><Year>2006</Year><Month>08</Month><Day>02</Day></DateCompleted><DateRevised><Year>2013</Year><Month>11</Month><Day>21</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Print">1195-1982</ISSN><JournalIssue CitedMedium="Print"><Volume>13</Volume><Issue>3</Issue><PubDate><MedlineDate>2006 May-Jun</MedlineDate></PubDate></JournalIssue><Title>Journal of travel medicine</Title><ISOAbbreviation>J Travel Med</ISOAbbreviation></Journal><ArticleTitle>Mefloquine-induced pneumonitis.</ArticleTitle><Pagination><MedlinePgn>172-4</MedlinePgn></Pagination><Abstract><AbstractText>Mefloquine is indicated as oral treatment and as prophylaxis for malaria in areas where chloroquine-resistant malaria is present. Gastrointestinal and neuropsychiatric side effects of mefloquine are well known. More severe neuropsychiatric disorders such as psychosis, depression, hallucinations, and seizures are also reported in the literature. We are reporting a case of drug-induced pneumonia due to mefloquine. This diagnosis was confirmed 4 months after the adverse event, after restarting the same malaria prophylaxis, which could be considered as an unintentional provocation test. This is the third case report in the literature of acute lung injury caused by mefloquine.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Soentjens</LastName><ForeName>Patrick</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Department of Internal Medicine, University Hospital Gasthuisberg, Leuven, Belgium.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Delanote</LastName><ForeName>Marc</ForeName><Initials>M</Initials></Author><Author ValidYN="Y"><LastName>Van Gompel</LastName><ForeName>Alfons</ForeName><Initials>A</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D002363">Case Reports</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>J Travel Med</MedlineTA><NlmUniqueID>9434456</NlmUniqueID><ISSNLinking>1195-1982</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000962">Antimalarials</NameOfSubstance></Chemical><Chemical><RegistryNumber>TML814419R</RegistryNumber><NameOfSubstance UI="D015767">Mefloquine</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000962" MajorTopicYN="N">Antimalarials</DescriptorName><QualifierName UI="Q000008" MajorTopicYN="N">administration & dosage</QualifierName><QualifierName UI="Q000009" MajorTopicYN="Y">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008288" MajorTopicYN="N">Malaria</DescriptorName><QualifierName UI="Q000517" MajorTopicYN="Y">prevention & control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015767" MajorTopicYN="N">Mefloquine</DescriptorName><QualifierName UI="Q000008" MajorTopicYN="N">administration & dosage</QualifierName><QualifierName UI="Q000009" MajorTopicYN="Y">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011014" MajorTopicYN="N">Pneumonia</DescriptorName><QualifierName UI="Q000139" MajorTopicYN="Y">chemically induced</QualifierName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2006</Year><Month>5</Month><Day>19</Day><Hour>9</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2006</Year><Month>8</Month><Day>3</Day><Hour>9</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2006</Year><Month>5</Month><Day>19</Day><Hour>9</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">16706949</ArticleId><ArticleId IdType="pii">JTM37</ArticleId><ArticleId IdType="doi">10.1111/j.1708-8305.2006.00037.x</ArticleId></ArticleIdList></PubmedData></pubmed><affiliations><list><country><li>Belgique</li></country></list><tree><noCountry><name sortKey="Delanote, Marc" sort="Delanote, Marc" uniqKey="Delanote M" first="Marc" last="Delanote">Marc Delanote</name><name sortKey="Van Gompel, Alfons" sort="Van Gompel, Alfons" uniqKey="Van Gompel A" first="Alfons" last="Van Gompel">Alfons Van Gompel</name></noCountry><country name="Belgique"><noRegion><name sortKey="Soentjens, Patrick" sort="Soentjens, Patrick" uniqKey="Soentjens P" first="Patrick" last="Soentjens">Patrick Soentjens</name></noRegion></country></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Sante/explor/ChloroquineV1/Data/PubMed/Checkpoint
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000681 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/PubMed/Checkpoint/biblio.hfd -nk 000681 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Sante
|area= ChloroquineV1
|flux= PubMed
|étape= Checkpoint
|type= RBID
|clé= pubmed:16706949
|texte= Mefloquine-induced pneumonitis.
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Checkpoint/RBID.i -Sk "pubmed:16706949" \
| HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Checkpoint/biblio.hfd \
| NlmPubMed2Wicri -a ChloroquineV1
| This area was generated with Dilib version V0.6.33. |  |